Skip to main content
. 2016 Aug 26;7(13):1861–1866. doi: 10.7150/jca.16279

Table 3.

Best response observed on CT-imaging after at least 4 cycles of FOLFIRINOX

Locally advanced Metastatic
(n = 17*) (n = 31*)
Complete response 0 0
Partial response 2 (12%) 10 (32%)
Stable disease 14 (82%) 16 (52%)
Progressive disease 1 (6%) 5 (16%)

* No radiological evaluation of 1 LAPC and 1 MPC patient